GlaxoSmithKline (GSK) opened an educational exhibit Tuesday in New York City to prepare the country for Alli, the first over-the-counter diet pill approved by the Food and Drug Administration. The company is hoping to manage unrealistic consumer expectations by making it clear the drug, which blocks the absorption of fat, is not a miracle pill and won’t replace diet and exercise.

HALLIBURTON

Halliburton will shift about 70 percent of its capital investment in the next five years to the Eastern Hemisphere, which includes oil and gas zones in the Middle East, Russia, Africa, the North Sea and East Asia, the company’s chief said Tuesday from headquarters in Dubai. Dave Lesar said Halliburton Co. (HAL) would expand its Mideast operations as it targets $80 billion in new business.